Australia markets closed

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.5700+0.0520 (+10.04%)
At close: 04:00PM EDT
0.5700 0.00 (0.00%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
54,900
29,497
3,597
3,662
0
Cost of revenue
76,128
33,527
10,077
38,857
0
Gross profit
-21,228
-4,030
-6,480
-35,195
0
Operating expenses
Research development
144,853
167,652
200,439
319,946
319,309
Selling general and administrative
184,295
165,510
140,326
209,969
239,950
Total operating expenses
236,218
240,232
238,765
529,915
559,259
Operating income or loss
-257,446
-244,262
-245,245
-565,110
-559,259
Interest expense
18,641
16,353
6,322
-
-
Total other income/expenses net
-52,967
38,707
20,310
1,851
-6,881
Income before tax
-319,276
-212,039
-230,225
-562,380
-560,370
Income tax expense
-25
-126
117
258
686
Income from continuing operations
-319,251
-211,913
-230,342
-562,638
-561,056
Net income
-319,251
-211,913
-230,342
-819,378
-618,695
Net income available to common shareholders
-319,251
-211,913
-230,342
-819,378
-618,695
Basic EPS
-0.63
-1.93
-2.93
-11.89
-9.95
Diluted EPS
-0.63
-1.93
-2.93
-11.89
-9.95
Basic average shares
101,507
109,825
78,585
68,190
62,178
Diluted average shares
101,507
109,825
78,585
68,190
62,178